Widiporization 10/160 mg
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Cosmax Pharma Co., Ltd.
MFDS item code 201802018 · Approved 2018.05.11
This product's status changed to Expired on 2023.05.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy
This treatment is used when blood pressure is not sufficiently controlled with amlodipine or valsartan monotherapy in patients with essential hypertension. In these cases, the two medications can be combined for more effective blood pressure reduction. This treatment helps improve blood pressure control and reduces the risk of cardiovascular complications. Therefore, it is appropriately used in patients who have difficulty controlling their blood pressure to help maintain health.
The recommended dose is 1 tablet once daily, taken with water regardless of meals. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. •5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. •5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. •10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). This medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to the ingredients of this medication or similar drugs, women who are pregnant or breastfeeding, patients with severe kidney or liver dysfunction, and those with certain heart diseases should not take this medication. Patients with low sodium or fluid levels in the body may be at risk for hypotension; therefore, their condition should be closely monitored before taking this medication, and blood pressure changes should be carefully observed during treatment. Patients with high potassium levels or those taking medications that can increase potassium should have their potassium levels checked frequently. Particular caution is required for patients with kidney vascular problems, kidney transplant recipients, and those with a history of angioedema; if symptoms of angioedema occur, the medication should be stopped immediately. Patients with heart failure or those who have had a myocardial infarction should evaluate kidney function changes carefully while taking this medication, and some patients with heart disease may experience worsening of symptoms while taking this medication, so caution is necessary. This medication has the potential for interactions when used with other antihypertensive agents, so it should be taken according to a doctor's instructions, especially when used with certain diuretics or NSAIDs, as kidney function should be regularly monitored. Caution is needed while driving or operating machinery, as dizziness or fatigue may occur. Women who are pregnant or may become pregnant are advised not to use this medication, and breastfeeding women are also recommended to avoid using this drug. Safety and efficacy have not been established in pediatric patients under 18 years of age, so its use is not recommended in this population. Overdose may result in dizziness and hypotension, so it is important to adhere to the prescribed dosage, and any unusual symptoms should be reported to a healthcare professional immediately.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory disturbance, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, diaphoresis, rash, itching, joint swelling, back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, limb edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, reduced libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, emotional changes, tremors, sensory loss, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, sore throat, hypercholesterolemia, hypoglycemia, neuroexcitation, sensory loss, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a closed container to protect it from air and moisture. The recommended storage temperature is between 1 degree and 30 degrees Celsius.
Bright yellow rectangular film-coated tablet
28 tablets (14 tablets/Alu-Alu X 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Cosmax Pharma Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.